By contrast, 23andme delivers high accuracy for genetic variants. Meaning, for those variants in their reference set they can tell with very high accuracy whether a given sample has a given allele. Interpretability of this information unfortunately varies greatly because genetics is hard, and a lot of the connections between genotypes and disease predisposition are complex and still being fully discovered. It’s for this specific reason that the FDA told 23andme off for providing disease predispositions; not because the genetic test itself is inaccurate (it isn’t).
For simple (Mendelian) disease predispositions, 23andme is essentially as accurate as any other for of genetic testing (which would at any rate also use genotyping).
On a side note, most of 23andme's reference set is limited to Europe, so it's even less accurate for a lot of people. Maybe things have changed?
The fact that DNA ancestry estimates are inaccurate for some people is largely unrelated to the technology (microarray vs sequencing), and rather to the fact that our reference set for ancestry is too sparse (especially outside of Europe).
[1] https://en.wikipedia.org/wiki/Whole_genome_sequencing [2] https://en.wikipedia.org/wiki/DNA_microarray [3] https://en.wikipedia.org/wiki/Precision_and_recall